Bansal Rahul K, Tanguay Simon, Finelli Antonio, Rendon Ricardo, Moore Ronald B, Breau Rodney H, Lacombe Louis, Black Peter C, Kawakami Jun, Drachenberg Darrel, Pautler Stephen, Saarela Olli, Liu Zhihui, Jewett Michael A S, Kapoor Anil
Division of Urology, McMaster University, Hamilton, ON.
Division of Urology, McGill University, Montreal, QC.
Can Urol Assoc J. 2017 Jun;11(6):182-187. doi: 10.5489/cuaj.4264.
We sought to determine the incidence, risk factors, and prognosis for patients with positive surgical margin (PSM) during partial nephrectomy (PN) for renal cell carcinoma (RCC).
From the Canadian Kidney Cancer information system (CKCis) database, a historical cohort of PN patients with PSM were identified and compared to negative surgical margin (NSM). Risk factors for PSM were examined through multivariable logistic regression. Kaplan-Meier curves were used to compare progression-free survival.
Of 1103 patients, 972 (88.1%), 71 (6.4%), and 60 (5.4%) had NSM, PSM, and unknown status, respectively. Median patient age and tumour size were 61 years and 3.0 cm for both groups. From multivariable analysis, pathological stage ≥T3 (odds ratio [OR] 2.51; 95% confidence interval [CI] 1.13-5.60) and Fuhrman grade 4 (OR 5.35; 95% CI 1.11-25.72) were associated with PSM, whereas age, operative technique, and tumour size were not. Forty-nine (5.0%) patients from the NSM cohort and seven (9.9%) from the PSM cohort had a local/systemic progression of disease (adjusted hazard ratio [HR] 1.4; 95% CI 0.6-3.6). There were three (0.3%) cancer-related deaths in the NSM group and none in the PSM group. After median followup of 19 (interquartile range [IQR] 5-42) and 15 (IQR 7-30) months, 855 (91.4%) and 61 (89.7%) patients were alive in the NSM and PSM groups, respectively.
PSM occurred in 6.4% of PNs performed for RCC in this pan-Canadian cohort. Higher stage and grade are associated with a higher risk of positive margin. The small association between a PSM and progression suggests that complete nephrectomy is not necessary in patients with a PSM. The main study limitations are lack of nephrometry score and possible reporting bias.
我们试图确定肾细胞癌(RCC)患者在接受部分肾切除术(PN)时手术切缘阳性(PSM)的发生率、危险因素及预后情况。
从加拿大肾癌信息系统(CKCis)数据库中,识别出具有PSM的PN患者的历史队列,并与手术切缘阴性(NSM)患者进行比较。通过多变量逻辑回归分析PSM的危险因素。采用Kaplan-Meier曲线比较无进展生存期。
1103例患者中,分别有972例(88.1%)、71例(6.4%)和60例(5.4%)为NSM、PSM及状态未知。两组患者的中位年龄和肿瘤大小分别为61岁和3.0 cm。多变量分析显示,病理分期≥T3(比值比[OR] 2.51;95%置信区间[CI] 1.13 - 5.60)和Fuhrman 4级(OR 5.35;95% CI 1.11 - 25.72)与PSM相关,而年龄、手术技术和肿瘤大小则无关。NSM队列中有49例(5.0%)患者和PSM队列中有7例(9.9%)患者出现疾病局部/全身进展(校正风险比[HR] 1.4;95% CI 0.6 - 3.6)。NSM组有3例(0.3%)与癌症相关的死亡病例,PSM组无死亡病例。在中位随访19(四分位间距[IQR] 5 - 42)个月和15(IQR 7 - 30)个月后,NSM组和PSM组分别有855例(91.4%)和61例(89.7%)患者存活。
在这个全加拿大队列中,6.4%接受RCC手术的PN患者出现PSM。更高的分期和分级与切缘阳性风险增加相关。PSM与疾病进展之间的微弱关联表明,PSM患者不一定需要进行根治性肾切除术。主要研究局限性在于缺乏肾计量评分以及可能存在报告偏倚。